Hamilton Thorne Ltd (HTLZF) 0.3330 $HTLZF
Hamilton Thorne Announces Record Third Quarter and Nine-Month Sales and Net Income
Marketwired - Tue Nov 25, 7:03AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the third quarter and nine-month period ended September 30, 2014.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Comments on Unusual Market Activity
Marketwired - Wed Nov 19, 2:53PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported that, in view of the unusual market activity in the common shares of the Company, the Investment Industry Regulatory Organization of Canada (IIROC) has contacted the Company in accordance with its usual practice. While it ordinarily does not comment on market activity or market rumors, the Company confirmed that it is not aware of any material corporate developments that could account for the unusual trading activity.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Announces Initial Closing of Over-Subscribed CDN$750,000 Private Placement
Marketwire Canada - Tue Nov 11, 3:45PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"
, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the initial closing of its previously announced non-brokered private placement.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Announces Private Placement Unit Offering of Up to CDN$750,000
Marketwire Canada - Wed Oct 22, 3:33PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company" , a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it is proposing to issue, on a non-brokered private placement basis, an aggregate of up to 7,500,000 Units ("Units) at an offering price of CDN$0.10 per Unit for aggregate gross proceeds of up to approximately CDN$750,000 (subject to increase at the discretion of the board of directors) (the "Offering" . Each Unit will consist of one common share (each, a "Common Share" of the Company and one common share purchase warrant (each, a "Warrant" . Each Warrant will provide the holder the right to purchase a Common Share at CDN$0.20 for a period of twelve months following the closing (subject to acceleration in certain circumstances at the Company's sole discretion).
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Announces New CASA Products at 2014 American Society for Reproductive Medicine Meeting
Marketwire Canada - Tue Oct 21, 1:26PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced a number of product releases at the annual American Society for Reproductive Medicine meeting being held in Honolulu, Hawaii from October 18 to October 22, 2014.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Announces Record Second Quarter Sales and Fourth Consecutive Quarter of Net Income
Marketwire - Wed Aug 27, 3:16PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the second quarter and six month period ended June 30, 2014.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Receives Notification of Grant of Patent Right and CFDA Approval to Market Its LYKOS(R) Laser System in China
Marketwire Canada - Wed Jul 16, 7:20AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has received notice that the China Food and Drug Administration (CFDA) has approved the Company's cutting edge LYKOS(R) for sale to clinical markets in China. Concurrent to this, the Company is pleased to announce it has received a Notification to Grant Patent Right for Invention covering the Modular Laser Assembly that is at the heart of its LYKOS system.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne & Halotech DNA SL to Preview New, Automated DNA Fragmentation Software ESHRE 2014
Marketwire Canada - Fri Jun 27, 8:15AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it will preview its new, automated DNA Fragmentation software at the European Society for Human Reproduction and Embryology meeting to be held in Munich from June 29 to July 2, 2014.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Announces Annual and Special Meeting Voting Results
Marketwire - Wed Jun 18, 1:29AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company" , a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research market, is pleased to announce that all of the resolutions proposed at its annual general and special meeting of shareholders held on June 16, 2014 (the "Meeting" were duly passed.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Introduces Comprehensive Suite of Service and Support Offerings
Marketwire Canada - Mon Jun 16, 7:30AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the introduction of a comprehensive suite of service plans, preventive maintenance and training offerings to support its hardware and software products.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Announces Record Third Quarter and Nine-Month Sales and Net Income
Marketwired - Tue Nov 25, 7:03AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the third quarter and nine-month period ended September 30, 2014.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Comments on Unusual Market Activity
Marketwired - Wed Nov 19, 2:53PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported that, in view of the unusual market activity in the common shares of the Company, the Investment Industry Regulatory Organization of Canada (IIROC) has contacted the Company in accordance with its usual practice. While it ordinarily does not comment on market activity or market rumors, the Company confirmed that it is not aware of any material corporate developments that could account for the unusual trading activity.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Announces Initial Closing of Over-Subscribed CDN$750,000 Private Placement
Marketwire Canada - Tue Nov 11, 3:45PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"
, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the initial closing of its previously announced non-brokered private placement. HTL.VN: 0.390 (-0.020)
Hamilton Thorne Announces Private Placement Unit Offering of Up to CDN$750,000
Marketwire Canada - Wed Oct 22, 3:33PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"
, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it is proposing to issue, on a non-brokered private placement basis, an aggregate of up to 7,500,000 Units ("Units) at an offering price of CDN$0.10 per Unit for aggregate gross proceeds of up to approximately CDN$750,000 (subject to increase at the discretion of the board of directors) (the "Offering" . Each Unit will consist of one common share (each, a "Common Share" of the Company and one common share purchase warrant (each, a "Warrant" . Each Warrant will provide the holder the right to purchase a Common Share at CDN$0.20 for a period of twelve months following the closing (subject to acceleration in certain circumstances at the Company's sole discretion). HTL.VN: 0.390 (-0.020)
Hamilton Thorne Announces New CASA Products at 2014 American Society for Reproductive Medicine Meeting
Marketwire Canada - Tue Oct 21, 1:26PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced a number of product releases at the annual American Society for Reproductive Medicine meeting being held in Honolulu, Hawaii from October 18 to October 22, 2014.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Announces Record Second Quarter Sales and Fourth Consecutive Quarter of Net Income
Marketwire - Wed Aug 27, 3:16PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the second quarter and six month period ended June 30, 2014.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Receives Notification of Grant of Patent Right and CFDA Approval to Market Its LYKOS(R) Laser System in China
Marketwire Canada - Wed Jul 16, 7:20AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has received notice that the China Food and Drug Administration (CFDA) has approved the Company's cutting edge LYKOS(R) for sale to clinical markets in China. Concurrent to this, the Company is pleased to announce it has received a Notification to Grant Patent Right for Invention covering the Modular Laser Assembly that is at the heart of its LYKOS system.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne & Halotech DNA SL to Preview New, Automated DNA Fragmentation Software ESHRE 2014
Marketwire Canada - Fri Jun 27, 8:15AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it will preview its new, automated DNA Fragmentation software at the European Society for Human Reproduction and Embryology meeting to be held in Munich from June 29 to July 2, 2014.
HTL.VN: 0.390 (-0.020)
Hamilton Thorne Announces Annual and Special Meeting Voting Results
Marketwire - Wed Jun 18, 1:29AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"
, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research market, is pleased to announce that all of the resolutions proposed at its annual general and special meeting of shareholders held on June 16, 2014 (the "Meeting" were duly passed. HTL.VN: 0.390 (-0.020)
Hamilton Thorne Introduces Comprehensive Suite of Service and Support Offerings
Marketwire Canada - Mon Jun 16, 7:30AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the introduction of a comprehensive suite of service plans, preventive maintenance and training offerings to support its hardware and software products.
HTL.VN: 0.390 (-0.020)
